The digital version of our July 2021 print issue, an argument in favor of a multidisciplinary approach to limb salvage and look back at the career of a former Society for Vascular Surgery (SVS) president were among the most-read stories on the Vascular Specialist website during the month of July.
1. Vascular Specialist–July 2021
The July edition contains such highlights as guest editorialist Bhagwan Satiani, MD talking through the choice between autonomy, true partnership—or what he termed the slow drift to ‘thralldom’; a pair of features analyzing patient-report outcomes (PROs), including what they are and why vascular surgeons should care about them; and a discussion on the role of political action committees (PACs) in political influence.
2. Fighting the good fight: The case for multidisciplinary limb salvage in face of increasing diabetes, diversifying nation
Dramatic increases in rates of diabetes—particularly among Black females—through 2060 underscore the importance of a multidisciplinary team approach to limb salvage, Vincent Rowe, MD, professor of vascular surgery and endovascular therapy in the Keck School of Medicine at the University of Southern California (USC), Los Angeles, told Vascular Specialist.
3. Latest meta-analysis on paclitaxel in peripheral arterial disease provokes mixed reception
“There appears to be heightened risk of major amputation after use of paclitaxel-coated balloons [PCBs] in the peripheral arteries,” findings from a systematic review and meta-analysis of randomized controlled trials (RCTs) published in the European Journal of Vascular and Endovascular Surgery (EJVES) suggested.
4. A lifetime of achievement: Former SVS president looks back on career milestones
Former SVS President Bruce A. Perler, MD, looked back on his career highlights after picking up the Southern Association for Vascular Surgery’s prestigious Rudolph Matas Lifetime Achievement Award, which recognizes a lifetime of excellence, achievement and contributions to the field of vascular surgery.
5. Endologix receives FDA Breakthrough Device designation for ChEVAS system
Endologix announced that the company’s ChEVAS (chimney endovascular aneurysm sealing) system had been granted Breakthrough Device designation from the Food and Drug Administration (FDA).
6. AVFs contribute to higher survival of hemodialysis patients with COVID-19
A new study published online in The Journal of Vascular Access (JVA) found that arteriovenous fistulas (AVFs) contribute to higher survival of hemodialysis patients with COVID-19. Authors Ahmet Murt, MD, of Istanbul University-Cerrahpasa, Istanbul, Turkey, and colleagues urged that end-stage renal disease (ESRD) patients “be given the opportunity to have their vascular access properly created,” even in the pandemic era.
7. Vascular Connections–August 2021 (Preview Edition)
The Vascular Annual Meeting (VAM) preview issue of Vascular Connections—the official conference newspaper—features a look ahead to some VAM highlights, including: the Crawford Forum agenda put together by new SVS President Ali AbuRahma, MD; the 2021 SVS Foundation Resident Research Award-winning paper; the Vascular & Endovascular Surgery Society (VESS) session at VAM, which doubles as VESS’ Spring Meeting; and previews of key scientific talks across a slew of VAM plenary sessions.
8. SVS clinical practice guidelines on popliteal artery aneurysms published
The SVS released new clinical practice guidelines to ensure that patients with popliteal artery aneurysms—the most common outside of the brain and abdominal aorta—receive appropriate treatment and care.
9. WFVS undergoes transformation, looks for vascular ’haves‘ to better help ‘have nots‘
The World Federation of Vascular Societies (WFVS) entered a new era of transformation, seeking to better pave the way for disparate vascular surgeons and societies to disseminate the latest science and best practices to every corner of the globe. Secretary-General Palma Shaw, MD, talked through the details.
10. OBL: Keys to success in the outpatient setting
The ability to pivot in the face of changes to reimbursement while still meeting the needs of patients is a key facet of success in the office-based lab (OBL). This was among the key messages delivered by Brian DeRubertis, MD, professor of surgery at UCLA School of Medicine in Los Angeles, in a talk delivered at the Pacific Northwest Endovascular Conference (PNEC) in Seattle.
